Abingdon Health (LON:ABDX) Reaches New 52-Week Low – Should You Sell?

Abingdon Health Plc (LON:ABDXGet Free Report)’s stock price hit a new 52-week low during trading on Friday . The stock traded as low as GBX 6.50 ($0.08) and last traded at GBX 6.82 ($0.09), with a volume of 49750 shares traded. The stock had previously closed at GBX 6.75 ($0.09).

Abingdon Health Trading Up 1.0 %

The firm has a market cap of £13.21 million, a price-to-earnings ratio of -16.58 and a beta of 0.13. The business has a fifty day moving average of GBX 7.60 and a two-hundred day moving average of GBX 8.14. The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95.

Abingdon Health Company Profile

(Get Free Report)

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.

Recommended Stories

Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.